What is the efficacy of intravenous vitamin C in the treatment of metastatic pancreatic cancer when combined with standard chemotherapy agents such as gemcitabine and erlotinib?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Intravenous vitamin C, when added to standard chemotherapy regimens like gemcitabine and nab-paclitaxel, appears to improve survival outcomes in metastatic pancreatic cancer; however, additional research is needed to confirm these findings and evaluate its effectiveness with other therapies.

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Vitamin C and Antioxidants Research Pancreatitis Pathology and Treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN